Want to see IN:ROSSARI full AI Analyst Report?
Rossari Biotech Ltd (ROSSARI) Ratios
Rossari Biotech Ltd Ratios
IN:ROSSARI's free cash flow for Q2 2027 was $0.00. For the 2027 fiscal year, IN:ROSSARI's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.57 | 1.94 | 1.99 | 2.08 | 2.07 |
| Quick Ratio | 1.05 | 1.28 | 1.32 | 1.54 | 1.42 |
| Cash Ratio | 0.12 | 0.11 | 0.06 | 0.20 | 0.13 |
| Solvency Ratio | 0.24 | 0.29 | 0.36 | 0.38 | 0.32 |
| Operating Cash Flow Ratio | 0.06 | 0.26 | 0.10 | 0.44 | 0.10 |
| Short-Term Operating Cash Flow Coverage | 0.14 | 1.56 | 0.60 | 3.89 | 3.48 |
| Net Current Asset Value | $ 2.80B | $ 3.32B | $ 3.19B | $ 2.69B | $ 1.58B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.11 | 0.08 | 0.05 | 0.01 |
| Debt-to-Equity Ratio | 0.33 | 0.18 | 0.11 | 0.08 | 0.01 |
| Debt-to-Capital Ratio | 0.25 | 0.16 | 0.10 | 0.07 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.08 | 0.03 | 0.04 | 0.00 |
| Financial Leverage Ratio | 1.72 | 1.60 | 1.50 | 1.49 | 1.56 |
| Debt Service Coverage Ratio | 0.66 | 2.05 | 2.29 | 2.85 | 7.36 |
| Interest Coverage Ratio | 7.24 | 28.90 | 9.63 | 6.95 | 10.43 |
| Debt to Market Cap | 0.20 | 0.06 | 0.03 | 0.02 | 0.00 |
| Interest Debt Per Share | 83.89 | 42.59 | 25.03 | 17.46 | 3.84 |
| Net Debt to EBITDA | 1.20 | 0.61 | 0.36 | 0.02 | -0.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.60% | 31.10% | 28.76% | 16.88% | 15.42% |
| EBIT Margin | 8.63% | 9.52% | 10.76% | 9.16% | 9.82% |
| EBITDA Margin | 11.93% | 12.74% | 14.05% | 12.79% | 13.06% |
| Operating Profit Margin | 8.63% | 24.74% | 10.19% | 9.36% | 8.90% |
| Pretax Profit Margin | 8.45% | 8.90% | 9.70% | 8.71% | 9.19% |
| Net Profit Margin | 6.23% | 6.56% | 7.14% | 6.48% | 6.59% |
| Continuous Operations Profit Margin | 6.23% | 6.56% | 7.14% | 6.48% | 6.59% |
| Net Income Per EBT | 73.68% | 73.64% | 73.58% | 74.37% | 71.67% |
| EBT Per EBIT | 97.94% | 35.98% | 95.18% | 93.04% | 103.21% |
| Return on Assets (ROA) | 6.52% | 7.19% | 8.31% | 7.84% | 7.77% |
| Return on Equity (ROE) | 11.19% | 11.50% | 12.47% | 11.72% | 12.13% |
| Return on Capital Employed (ROCE) | 13.79% | 37.85% | 16.26% | 15.19% | 13.72% |
| Return on Invested Capital (ROIC) | 8.37% | 26.04% | 11.24% | 10.88% | 9.75% |
| Return on Tangible Assets | 7.23% | 8.26% | 9.98% | 9.80% | 9.80% |
| Earnings Yield | 7.12% | 4.00% | 3.38% | 3.26% | 1.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.29 | 4.37 | 4.30 | 4.67 | 4.84 |
| Payables Turnover | 5.88 | 5.01 | 5.95 | 7.60 | 5.97 |
| Inventory Turnover | 4.70 | 4.04 | 4.62 | 7.30 | 5.85 |
| Fixed Asset Turnover | 3.27 | 3.74 | 4.31 | 5.07 | 4.26 |
| Asset Turnover | 1.05 | 1.10 | 1.16 | 1.21 | 1.18 |
| Working Capital Turnover Ratio | 5.03 | 4.50 | 4.62 | 4.81 | 5.71 |
| Cash Conversion Cycle | 100.63 | 101.03 | 102.64 | 80.12 | 76.65 |
| Days of Sales Outstanding | 85.08 | 83.52 | 84.94 | 78.14 | 75.40 |
| Days of Inventory Outstanding | 77.61 | 90.42 | 79.02 | 49.99 | 62.41 |
| Days of Payables Outstanding | 62.05 | 72.92 | 61.32 | 48.01 | 61.17 |
| Operating Cycle | 162.69 | 173.95 | 163.96 | 128.13 | 137.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.16 | 24.82 | 7.83 | 27.50 | 5.35 |
| Free Cash Flow Per Share | -39.65 | -3.81 | -15.94 | 21.69 | -1.62 |
| Dividend Paid and CapEx Coverage Ratio | 0.17 | 0.85 | 0.32 | 4.25 | 0.72 |
| Capital Expenditure Coverage Ratio | 0.17 | 0.87 | 0.33 | 4.61 | 0.77 |
| Operating Cash Flow Coverage Ratio | 0.10 | 0.63 | 0.36 | 2.05 | 3.48 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.07 | 0.02 | 0.09 | 0.02 |
| Free Cash Flow Yield | -10.47% | -0.62% | -2.28% | 3.64% | -0.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.05 | 24.98 | 29.57 | 30.63 | 51.19 |
| Price-to-Sales (P/S) Ratio | 0.87 | 1.64 | 2.11 | 1.98 | 3.37 |
| Price-to-Book (P/B) Ratio | 1.57 | 2.88 | 3.69 | 3.59 | 6.21 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.55 | -161.88 | -43.90 | 27.49 | -563.88 |
| Price-to-Operating Cash Flow Ratio | 46.41 | 24.81 | 89.33 | 21.68 | 170.31 |
| Price-to-Earnings Growth (PEG) Ratio | 1.51 | 5.97 | 1.37 | 3.31 | 3.58 |
| Enterprise Value Multiple | 8.53 | 13.47 | 15.39 | 15.53 | 25.66 |
| Enterprise Value | 24.40B | 35.71B | 39.58B | 32.89B | 49.71B |
| EV to EBITDA | 8.53 | 13.47 | 15.39 | 15.53 | 25.66 |
| EV to Sales | 1.02 | 1.72 | 2.16 | 1.99 | 3.35 |
| EV to Free Cash Flow | -11.12 | -169.51 | -44.96 | 27.52 | -560.61 |
| EV to Operating Cash Flow | 54.02 | 25.98 | 91.50 | 21.70 | 169.32 |
| Tangible Book Value Per Share | 200.38 | 169.88 | 142.16 | 116.51 | 99.30 |
| Shareholders’ Equity Per Share | 240.82 | 214.09 | 189.77 | 166.05 | 146.80 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.26 | 0.26 | 0.26 | 0.28 |
| Revenue Per Share | 432.81 | 375.70 | 331.56 | 300.44 | 270.38 |
| Net Income Per Share | 26.95 | 24.63 | 23.67 | 19.46 | 17.81 |
| Tax Burden | 0.74 | 0.74 | 0.74 | 0.74 | 0.72 |
| Interest Burden | 0.98 | 0.94 | 0.90 | 0.95 | 0.94 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.12 | 0.06 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.30 | 1.01 | 0.33 | 1.05 | 0.22 |
Currency in INR